Title |
RNY-derived small RNAs as a signature of coronary artery disease
|
---|---|
Published in |
BMC Medicine, October 2015
|
DOI | 10.1186/s12916-015-0489-y |
Pubmed ID | |
Authors |
Emanuela Repetto, Laeticia Lichtenstein, Zoheir Hizir, Nedra Tekaya, Mohamed Benahmed, Jean-Bernard Ruidavets, Laure-Emmanuelle Zaragosi, Bertrand Perret, Laura Bouchareychas, Annelise Genoux, Romain Lotte, Raymond Ruimy, Jean Ferrières, Pascal Barbry, Laurent O. Martinez, Michele Trabucchi |
Abstract |
Data from next generation sequencing technologies uncovered the existence of many classes of small RNAs. Recent studies reported that small RNAs are released by cells and can be detected in the blood. In this report, we aimed to discover the occurrence of novel circulating small RNAs in coronary artery disease (CAD). We used high-throughput sequencing of small RNAs from human and mouse apoptotic primary macrophages, and analyzed the data by empirical Bayes moderated t-statistics to assess differential expression and the Benjamini and Hochberg method to control the false discovery rate. Results were then confirmed by Northern blot and RT-qPCR in foam cells and in two animal models for atherosclerosis, namely ApoE (-/-) and Ldlr (-/-) mouse lines. Quantitative RT-PCR to detect identified small RNAs, the RNY-derived small RNAs, was performed using sera of 263 patients with CAD compared to 514 matched healthy controls; the Student t-test was applied to statistically assess differences. Associations of small RNAs with clinical characteristics and biological markers were tested using Spearman's rank correlations, while multivariate logistic regressions were performed to test the statistical association of small RNA levels with CAD. Here, we report that, in macrophages stimulated with pro-apoptotic or pro-atherogenic stimuli, the Ro-associated non-coding RNAs, called RNYs or Y-RNAs, are processed into small RNAs (~24-34 nt) referred to as small-RNYs (s-RNYs), including s-RNY1-5p processed from RNY1. A significant upregulation of s-RNY expression was found in aortic arches and blood plasma from ApoE (-/-) and Ldlr (-/-) mice and in serum from CAD patients (P <0.001). Biostatistical analysis revealed a positive association of s-RNY1-5p with hs-CRP and ApoB levels; however, no statistical interaction was found between either of these two markers and s-RNY1-5p in relation to the CAD status. Levels of s-RNY1-5p were also independent from statin and fibrate therapies. Our results position the s-RNY1-5p as a relevant novel independent diagnostic biomarker for atherosclerosis-related diseases. Measurement of circulating s-RNY expression would be a valuable companion diagnostic to monitor foam cell apoptosis during atherosclerosis pathogenesis and to evaluate patient's responsiveness to future therapeutic strategies aiming to attenuate apoptosis in foam cells in advanced atherosclerotic lesions. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 2 | 50% |
Côte d'Ivoire | 1 | 25% |
United Kingdom | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 50% |
Scientists | 1 | 25% |
Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 66 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 26% |
Student > Ph. D. Student | 13 | 20% |
Student > Doctoral Student | 6 | 9% |
Student > Bachelor | 5 | 8% |
Student > Master | 4 | 6% |
Other | 5 | 8% |
Unknown | 16 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 13 | 20% |
Agricultural and Biological Sciences | 12 | 18% |
Medicine and Dentistry | 11 | 17% |
Immunology and Microbiology | 4 | 6% |
Business, Management and Accounting | 2 | 3% |
Other | 6 | 9% |
Unknown | 18 | 27% |